Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT01371981 · COMPLETED

Trial details

NCT number: NCT01371981
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma

Start date: 2011-07-06
Primary completion: 2019-03-31
Enrollment: 1645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.